L-Asparaginases of Extremophilic Microorganisms in Biomedicine

被引：0

作者：

M. V. Dumina

M. A. Eldarov

D. D. Zdanov

N. N. Sokolov

机构：

[1] Federal Research Center “Fundamentals of Biotechnology” of the Russian Academy of Sciences,

[2] Institute of Biomedical Chemistry,undefined

来源：

Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry | 2020年 / 14卷

关键词：

: L-asparaginase; antitumor drug; extremophilic microorganisms; stability; structural and functional properties;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：277 / 296

页数：19

共 538 条

[1]

Solomon B.(2017)Grinnan, E.L., Burck, P.J., Frank, B.H., Boeck, L.D., and Squires, R.W J. Blood Disord. Transfus 8 24-22

[2]

Parihar N.(2018), Bioeng. Biotechnol 6 1-254

[3]

Ayodele L.(2006)undefined Int. J. Nanomedicine 1 241-262

[4]

Hughes M.(2014)undefined Leuk. Lymphoma 55 256-513

[5]

Brumano L.P.(2013)undefined Biomeditsinskaya Khimiya 59 498-324

[6]

da Silva F.V.S.(2015)undefined Biomeditsinskaya Khimiya 61 312-3533

[7]

Costa-Silva T.A.(2014)undefined Blood 123 3532-882

[8]

Apolinario A.C.(2003)undefined Leuk. Lymphoma 44 879-113

[9]

Santos J.H.P.M.(1998)undefined Crit. Rev. Oncol. Hematol 28 97-2739

[10]

Kleingesinds E.K.(2002)undefined Blood 99 2734-72